<strong>Introduction:</strong> <span><span><span style="font-family:""><span style="font-family:Verdana;">Caesarean section (CS) is a major reproductive hea...<strong>Introduction:</strong> <span><span><span style="font-family:""><span style="font-family:Verdana;">Caesarean section (CS) is a major reproductive health intervention to improve maternal and foetal outcomes if appropriately performed. </span><span style="font-family:Verdana;">This study aimed to assess the quality of Caesarean sections (CS) in a rural</span> <span><span style="font-family:Verdana;">setting in Cameroon. </span><b><span style="font-family:Verdana;">Materials and Methods: </span></b><span style="font-family:Verdana;">A prospective study con</span></span><span style="font-family:Verdana;">ducted in 3 hospitals from February 1</span><sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2020 to April 30</span><sup><span style="font-family:Verdana;">th</span></sup><span style="font-family:Verdana;"> 2020. One hundred and twenty women who had a CS were included. Data were grouped into 5 categories: </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">1</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">) Sociodemographic and obstetrical characteristics, </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">2</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">) Geographic and financial access, </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">3</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">) Diagnostic procedures, </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">4</span></span></span><span style="font-family:Verdana;"><span style="font-famil展开更多
Heart disease in pregnancy is the cause of significant maternal and perinatal morbidity. We wanted to evaluate the maternal and perinatal outcomes </span><a name="_Hlk89187857"></a><span...Heart disease in pregnancy is the cause of significant maternal and perinatal morbidity. We wanted to evaluate the maternal and perinatal outcomes </span><a name="_Hlk89187857"></a><span style="font-family:Verdana;">of pregnant women with heart disease in Yaoundé, Cameroon. This was a cross sectional study with retrospective data collection of 45 pregnancies in 42 women with heart disease followed at three Yaoundé referral hospitals in Yaoundé, Cameroon from January 1</span><sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2015 to December 31</span><sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2020. We collected data on maternal obstetrical and perinatal outcomes. The frequency of pregnancies with heart diseases was 0.1%. The mean maternal age was 29.05 ± 6.5 years. At first antenatal visit, all patients were in class I (84.4%) and II (15.6%) of the New-York Heart Association (NYHA) functional class. Valvular heart disease (51.1%) was the most common type followed by cardiomyopathy (37.7%). Over half of the deliveries were vaginal (51.1%). A cesarean section was generally indicated for the usual obstetrical reasons (54.5%) and for heart disease (31.8%). Complications included 17 (37.7%) cases of heart failure, 6 (13.3%) cases of pulmonary edema, 2 (04.4%) cases of pulmonary </span><span style="font-family:Verdana;">embolism, 3 (06.6%) maternal deaths and 3 (06.3%) perinatal deaths, 14 (29.7%)</span><span style="font-family:Verdana;"> premature births and 3 cases of (6.3%) intrauterine growth retardation. The maternal deaths were cases complicated by pulmonary edema and all had di</span><span style="font-family:Verdana;">lated cardiomyopathy. The maternal and perinatal outcomes of pregnant women with heart disease </span></span><span style="font-family:Verdana;">are</span><span style="font-family:Verdana;"> marked in our environment by increased</span><span style="font-family:Verdana;"> morbidity and mortality. Therefore, it 展开更多
文摘<strong>Introduction:</strong> <span><span><span style="font-family:""><span style="font-family:Verdana;">Caesarean section (CS) is a major reproductive health intervention to improve maternal and foetal outcomes if appropriately performed. </span><span style="font-family:Verdana;">This study aimed to assess the quality of Caesarean sections (CS) in a rural</span> <span><span style="font-family:Verdana;">setting in Cameroon. </span><b><span style="font-family:Verdana;">Materials and Methods: </span></b><span style="font-family:Verdana;">A prospective study con</span></span><span style="font-family:Verdana;">ducted in 3 hospitals from February 1</span><sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2020 to April 30</span><sup><span style="font-family:Verdana;">th</span></sup><span style="font-family:Verdana;"> 2020. One hundred and twenty women who had a CS were included. Data were grouped into 5 categories: </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">1</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">) Sociodemographic and obstetrical characteristics, </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">2</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">) Geographic and financial access, </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">3</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">) Diagnostic procedures, </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">4</span></span></span><span style="font-family:Verdana;"><span style="font-famil
文摘Heart disease in pregnancy is the cause of significant maternal and perinatal morbidity. We wanted to evaluate the maternal and perinatal outcomes </span><a name="_Hlk89187857"></a><span style="font-family:Verdana;">of pregnant women with heart disease in Yaoundé, Cameroon. This was a cross sectional study with retrospective data collection of 45 pregnancies in 42 women with heart disease followed at three Yaoundé referral hospitals in Yaoundé, Cameroon from January 1</span><sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2015 to December 31</span><sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2020. We collected data on maternal obstetrical and perinatal outcomes. The frequency of pregnancies with heart diseases was 0.1%. The mean maternal age was 29.05 ± 6.5 years. At first antenatal visit, all patients were in class I (84.4%) and II (15.6%) of the New-York Heart Association (NYHA) functional class. Valvular heart disease (51.1%) was the most common type followed by cardiomyopathy (37.7%). Over half of the deliveries were vaginal (51.1%). A cesarean section was generally indicated for the usual obstetrical reasons (54.5%) and for heart disease (31.8%). Complications included 17 (37.7%) cases of heart failure, 6 (13.3%) cases of pulmonary edema, 2 (04.4%) cases of pulmonary </span><span style="font-family:Verdana;">embolism, 3 (06.6%) maternal deaths and 3 (06.3%) perinatal deaths, 14 (29.7%)</span><span style="font-family:Verdana;"> premature births and 3 cases of (6.3%) intrauterine growth retardation. The maternal deaths were cases complicated by pulmonary edema and all had di</span><span style="font-family:Verdana;">lated cardiomyopathy. The maternal and perinatal outcomes of pregnant women with heart disease </span></span><span style="font-family:Verdana;">are</span><span style="font-family:Verdana;"> marked in our environment by increased</span><span style="font-family:Verdana;"> morbidity and mortality. Therefore, it
